Table 2 Components and total CVS of most recent CT imaging study
From: Quantification of Proteus syndrome-associated lung disease
Components and total Clinician Visual Score | |||
|---|---|---|---|
Components of Clinician Visual Score | Frequency | Clinician Visual Score | Frequency |
Cysts | |||
Yes | 26 (59%) | 0 | 12 (27%) |
Minimal | 8 | 1 | 3 (7%) |
Mild | 11 | 2 | 7 (16%) |
Moderate | 3 | 3 | 2 (5%) |
Severe | 4 | 4 | 1 (2%) |
No | 18 (41%) | 5 | 3 (7%) |
6 | 5 (11%) | ||
Ground glass | 7 | 2 (5%) | |
Yes | 28 (64%) | 8 | 3 (7%) |
Minimal | 16 | 9 | 1 (2%) |
Mild | 7 | 10 | 2 (5%) |
Moderate | 2 | 11 | 2 (5%) |
Severe | 3 | 12 | 1 (2%) |
No | 16 (36%) | ||
Hyperlucent Lung | |||
Yes | 26 (59%) | ||
Minimal | 6 | ||
Mild | 3 | ||
Moderate | 9 | ||
Severe | 8 | ||
No | 18 (41%) | ||